Literature DB >> 16542037

Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats.

Leonie Am Welberg1, Becky Kinkead, Kv Thrivikraman, Michael J Huerkamp, Charles B Nemeroff, Paul M Plotsky.   

Abstract

We evaluated the effect of ketamine-xylazine-acepromazine anesthesia (31.25, 6.25, and 1.25 mg/kg subcutaneously, respectively) on postsurgical recovery in male Sprague-Dawley (Crl:SD) rats undergoing laparotomy with and without the postoperative analgesic ketorolac. Recovery was determined by changes in body weight (BW) and water intake. The time of ketorolac administration (5 mg/kg intramuscularly), 60 min after anesthetic injection, was based on return of the pedal withdrawal reflex in Long-Evans (HsdBlu:LE) rats undergoing stereotaxic surgery in a separate experiment. Results were compared with those of housing and anesthesia controls as well as of laparotomized rats receiving a single sugared treat for nonpharmacologic management of postoperative pain. Surgery took place on day 0; the first 24 h postsurgery was considered the "acute phase," and days 1 through 4 comprised the "recovery phase." Results suggest that 1) the anesthetic mixture is fast- and long-acting and provides sufficient immobility, loss of consciousness, and analgesia; 2) during the acute phase, rats subjected to laparotomy did not lose more BW than rats exposed to anesthesia alone; 3) water intake during both phases did not significantly differ between treatment groups; 4) postsurgical ketorolac administration did not minimize BW loss during the acute phase nor cause any adverse effects under this anesthetic regimen; and 5) provision of single sugared treats had salutary effects on BW recovery. This finding suggests that postsurgical BW loss after use of this anesthetic mixture is due to distress unrelated to pain; this nonpain distress may have masked potential beneficial effects of ketorolac.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542037

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  13 in total

1.  Evaluation of Analgesic Efficacy of Meloxicam and 2 Formulations of Buprenorphine after Laparotomy in Female Sprague-Dawley Rats.

Authors:  Elizabeth A Nunamaker; Julia L Goldman; Cynthia R Adams; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-08-09       Impact factor: 1.232

2.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

3.  Dose regimens, variability, and complications associated with using repeat-bolus dosing to extend a surgical plane of anesthesia in laboratory mice.

Authors:  Samer M Jaber; F Claire Hankenson; Kathleen Heng; Andrew McKinstry-Wu; Max B Kelz; James O Marx
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

4.  Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Xiaoping Chen; Stephen Tomlinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

5.  Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: safety, stability, and efficacy over time.

Authors:  Brett J Taylor; Steven A Orr; Jennifer L Chapman; Diana E Fisher
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-11       Impact factor: 1.232

6.  Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice.

Authors:  Sandra Buitrago; Thomas E Martin; Joanne Tetens-Woodring; Alan Belicha-Villanueva; Gregory E Wilding
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

7.  Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine.

Authors:  Matthew P Brennan; Albert J Sinusas; Tamas L Horvath; J G Collins; Martha J Harding
Journal:  Lab Anim (NY)       Date:  2009-03       Impact factor: 12.625

8.  Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Authors:  Elizabeth I Flandreau; Chase H Bourke; Kerry J Ressler; Wylie W Vale; Charles B Nemeroff; Michael J Owens
Journal:  Psychoneuroendocrinology       Date:  2012-12-23       Impact factor: 4.905

9.  Anesthetic effects and body weight changes associated with ketamine-xylazine-lidocaine administered to CD-1 mice.

Authors:  Urshulaa Dholakia; Stuart C Clark-Price; Stephanie C J Keating; Adam W Stern
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

10.  Anesthetic efficacy of ketamine-diazepam, ketamine-xylazine, and ketamine-acepromazine in Caspian Pond turtles (Mauremys caspica).

Authors:  Milad Adel; Amin Bigham Sadegh; Vincenzo Arizza; Hossein Abbasi; Luigi Inguglia; Hasan Nasrollahzadeh Saravi
Journal:  Indian J Pharmacol       Date:  2017 Jan-Feb       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.